Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated Versus Standard Hepatitis B Vaccination in End Stage Renal Disease Patients
TCTR20210327001Phase 3Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- May 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start May 2021; status: not yet recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on TCTR20210327001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210327001.